Covered recipient · General Payments record
AMBER L POST
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$10,456.17
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.21 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $50.52 | 2 |
| Daiichi Sankyo Inc. | $47.01 | 2 |
| Exeltis, USA Inc. | $38.27 | 2 |
| Sage Therapeutics, Inc. | $34.67 | 2 |
| Organon LLC | $31.51 | 2 |
| Exact Sciences Corporation | $20.28 | 1 |
| Hologic Sales and Service, LLC | $17.52 | 1 |
| Sumitomo Pharma America, Inc. | $17.33 | 1 |
| Astellas Pharma US Inc | $16.94 | 1 |
| Ethicon US, LLC | $16.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.25 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105299005 | CMS |
| ABBVIE INC. | $23.27 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105299009 | CMS |
| Astellas Pharma US Inc | $16.94 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268372 | CMS |
| Daiichi Sankyo Inc. | $23.19 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089470445 | CMS |
| Daiichi Sankyo Inc. | $23.82 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089470447 | CMS |
| Ethicon US, LLC | $16.16 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077651456 | CMS |
| Exact Sciences Corporation | $20.28 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114839365 | CMS |
| Exeltis, USA Inc. | $14.76 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150002338 | CMS |
| Exeltis, USA Inc. | $23.51 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150002340 | CMS |
| Hologic Sales and Service, LLC | $17.52 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084897057 | CMS |
| Organon Llc | $16.40 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136296589 | CMS |
| Organon Llc | $15.11 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136296591 | CMS |
| Sage Therapeutics, Inc. | $21.59 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120410237 | CMS |
| Sage Therapeutics, Inc. | $13.08 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120401162 | CMS |
| Sumitomo Pharma America, Inc. | $17.33 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148905395 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.